MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
1.46 M |
Marktkapitalisierung |
$ 19.4 M |
EBITDA (LTM) |
$ -13.7 M |
P/E (LTM) |
- |
P/S (LTM) |
168.58 |
EPS (LTM) |
-5.43 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 136.96 | 1.16 % | $ 41.6 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 133.65 | 2.09 % | $ 6.25 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 8.7 | -22.27 % | $ 11.6 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 21.25 | -3.89 % | $ 616 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.59 | 1.92 % | $ 572 M | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 128.73 | -3.37 % | $ 16.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 22.9 | 0.88 % | $ 1.22 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
ICON Public Limited Company
ICLR
|
$ 137.9 | 0.8 % | $ 10.8 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Interpace Biosciences
IDXG
|
$ 1.7 | -5.56 % | $ 7.52 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 164.95 | 3.94 % | $ 26.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.51 | 0.89 % | $ 6.78 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 179.61 | 1.38 % | $ 24.3 B | NYSE,SPB |  Schweiz |
 |
Charles River Laboratories International
CRL
|
$ 184.52 | 1.75 % | $ 9.15 B | NYSE,SPB | USA |
 |
NeoGenomics
NEO
|
$ 10.61 | 4.07 % | $ 1.36 B | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
National Research Corporation
NRC
|
$ 19.96 | 1.53 % | $ 447 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 221.45 | 3.51 % | $ 21.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 451.97 | 0.86 % | $ 13 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.01 | -5.09 % | $ 371 M | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 11.58 | 5.46 % | $ 1.03 B | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.56 | 0.4 % | $ 25.2 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 6.73 | 0.15 % | $ 281 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 70.01 | 1.42 % | $ 4.19 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.38 | -2.26 % | $ 5.47 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 262.26 | 0.09 % | $ 21.8 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 496.58 | 1.93 % | $ 187 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.72 | 1.73 % | $ 259 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.22 | -0.86 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 195.52 | -0.4 % | $ 21.7 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |